Linong Ji

3PUBLICATIONS
35CO-AUTHORS
PharmacogenomicsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 30, 2022
A multicentre, randomized, double-blind, parallel, active- and placebo-controlled Phase 3 clinical study of the glucokinase activator PB-201 in treatment-naive patients with type 2 diabetes mellitus: A study protocol.

Ying Du, Leili Gao, Xinhua Xiao

|May 26, 2021
Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study.

Linong Ji, Ying Du, Min Xu

|Mar 09, 2021
Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study.

Linong Ji, Ying Du, Min Xu

Pageof 1

Frequent Collaborators

2 joint publications

Ying Du

2 joint publications

Min Xu

2 joint publications

Xiangjun Zhou

2 joint publications

Zhaohui Mo